New study shows trimbow helps COPD patients breathe easier and stick to treatment
NCT ID NCT03963167
First seen Mar 07, 2026 · Last updated May 15, 2026 · Updated 13 times
Summary
This study followed 661 Italian adults with moderate to severe COPD who were using the Trimbow inhaler. Researchers wanted to see if the medication improved their health status and how well they stuck to their treatment plan over 12 months. The study measured changes in a COPD symptom questionnaire and adherence to inhaler use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione Policlinico Gemelli
Rome, Italy
Conditions
Explore the condition pages connected to this study.